| Assay ID | Title | Year | Journal | Article |
|---|
| AID303924 | Binding affinity at CB1 receptor | 2007 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 17, Issue:24
| Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity. |
| AID262342 | Selectivity for rat CB1 receptor over mouse CB2 receptor | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids. |
| AID1230031 | Displacement of [3H]CP55940 from full length human recombinant CB2 receptor expressed in HEK293 cells after 90 mins by scintillation counting analysis | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID49852 | Binding affinity for Cannabinoid receptor 2 by the ability to displace radiolabeled CP-55940 from mouse spleen synaptosomes | 2002 | Bioorganic & medicinal chemistry letters, Dec-16, Volume: 12, Issue:24
| Novel 1',1'-chain substituted Delta(8)-tetrahydrocannabinols. |
| AID262341 | Displacement of [3H]CP-55940 from mouse spleen CB2 receptor | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids. |
| AID112375 | The compound was tested in vivo for locomotor stimulus in rats | 1991 | Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
| Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol. |
| AID1131793 | Hypothermic activity in ddN mouse assessed as reduction of rectal temperature at 10 mg/kg, iv after 1 hr | 1978 | Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
| Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol. |
| AID127281 | Compound was tested for activity in rhesus monkey behavioral test; Active | 1989 | Journal of medicinal chemistry, Jul, Volume: 32, Issue:7
| The importance of the orientation of the C9 substituent to cannabinoid activity. |
| AID1131794 | Hypothermic activity in ddN mouse assessed as reduction of rectal temperature at 20 mg/kg, iv after 1 hr | 1978 | Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
| Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol. |
| AID406563 | Selectivity ratio of Ki for human CB1 receptor to Ki for human CB2 receptor | 2008 | Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
| Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs. |
| AID1062664 | Half life in rat plasma at 200 uM by HPLC analysis | 2013 | Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
| Controlled-deactivation cannabinergic ligands. |
| AID1230040 | Neurobehavioral effect on Swiss Webster mouse assessed as tail-flick latency time at 5 mg/kg, ip (Rvb = 0.84 +/- 3.58 %) by mouse tetrad assay | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID262340 | Displacement of [3H]CP-55940 from rat brain CB1 receptor | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids. |
| AID1230036 | Neurobehavioral effect on Swiss Webster mouse assessed as catalepsy latency time at 5 mg/kg, ip (Rvb = 2.1 +/- 0.60 secs) by mouse tetrad assay | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID133195 | Psychotropic Effect evaluated by Mouse Ring Test at a dose of 10 mg/kg | 1990 | Journal of medicinal chemistry, Mar, Volume: 33, Issue:3
| Cannabimimetic activity of novel enantiomeric, benzofuran cannabinoids. |
| AID49491 | Binding affinity for Cannabinoid receptor 1 by the ability to displace radiolabeled CP-55940 from purified rat forebrain synaptosomes | 2002 | Bioorganic & medicinal chemistry letters, Dec-16, Volume: 12, Issue:24
| Novel 1',1'-chain substituted Delta(8)-tetrahydrocannabinols. |
| AID414288 | Selectivity ratio of Ki for human CB1 receptor to Ki for human CB2 receptor | 2009 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
| Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands. |
| AID1124420 | Induction of overt behavior in dog at 0.40 mg/kg, iv | 1979 | Journal of medicinal chemistry, Jul, Volume: 22, Issue:7
| Some 11-substituted tetrahydrocannabinols. Synthesis and comparison with the potent cannabinoid metabolites 11-hydroxytetrahydrocannabinols. |
| AID1133173 | Inhibition of mouse brain synaptosomal Lysophosphatidylcholine acyltransferase using substrate [32P]lysophosphatidylcholine and oleoyl-CoA | 1978 | Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
| Molar volume relationships and the specific inhibition of a synaptosomal enzyme by psychoactive cannabinoids. |
| AID1230042 | Neurobehavioral effect on Swiss Webster mouse assessed as tail-flick latency time at 20 mg/kg, ip (Rvb = 0.84 +/- 3.58 %) by mouse tetrad assay | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID116116 | The compound was tested in vivo for tail-flick latency in mice | 1991 | Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
| Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol. |
| AID239117 | Inhibition of [3H]CP-55940 binding to cannabinoid receptor 2 of mouse spleen membranes | 2005 | Journal of medicinal chemistry, Jul-14, Volume: 48, Issue:14
| Adamantyl cannabinoids: a novel class of cannabinergic ligands. |
| AID1230030 | Displacement of [3H]CP55940 from full length human recombinant CB1 receptor expressed in HEK293 cells after 90 mins by scintillation counting analysis | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID221602 | Percent inhibition measured in terms of the maximum possible effect (MPE)on latency by mouse tail-flick assay | 1992 | Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
| 5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. |
| AID112372 | The compound was tested in vivo for hypothermic activity in mice | 1991 | Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
| Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol. |
| AID40044 | Induction of yawning and scratching was determined in Baboons at a dose 0.1 mg/kg; absent | 1984 | Journal of medicinal chemistry, Oct, Volume: 27, Issue:10
| Activity of novel aminocannabinoids in baboons. |
| AID414286 | Binding affinity to human CB1 receptor transfected in HEK293 cells | 2009 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
| Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands. |
| AID49661 | Binding affinity towards cannabinoid receptor 1 in rat forebrain membranes. | 1999 | Bioorganic & medicinal chemistry letters, Aug-02, Volume: 9, Issue:15
| Novel conformationally restricted tetracyclic analogs of delta8-tetrahydrocannabinol. |
| AID311037 | Binding affinity to CB1 receptor | 2007 | Journal of medicinal chemistry, Jun-14, Volume: 50, Issue:12
| The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2. |
| AID221445 | Induction of ring immobility (catalepsy), measured by in vivo administration of drug in mouse | 1992 | Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
| 5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. |
| AID133196 | Psychotropic Effect evaluated by Mouse Ring Test at a dose of 1 mg/kg | 1990 | Journal of medicinal chemistry, Mar, Volume: 33, Issue:3
| Cannabimimetic activity of novel enantiomeric, benzofuran cannabinoids. |
| AID1230044 | Neurobehavioral effect on Swiss Webster mouse assessed as hot plate latency time at 5 mg/kg, ip (Rvb = 8.32 +/- 2.20 %) by mouse tetrad assay | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID391586 | Displacement of [3H]CP-55940 from CB1 receptor in rat brain synaptosome membrane | 2008 | Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
| Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands. |
| AID40043 | Induction of yawning and scratching was determined in Baboons at a dose 0.05 mg/kg; absent | 1984 | Journal of medicinal chemistry, Oct, Volume: 27, Issue:10
| Activity of novel aminocannabinoids in baboons. |
| AID1133174 | Antihemolytic potency against hypotonic lysis-induced erythrocytes (unknown origin) assessed as stabilization | 1978 | Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
| Molar volume relationships and the specific inhibition of a synaptosomal enzyme by psychoactive cannabinoids. |
| AID1124427 | Analgesic activity in sc dosed mouse by hot-plate method | 1979 | Journal of medicinal chemistry, Jul, Volume: 22, Issue:7
| Some 11-substituted tetrahydrocannabinols. Synthesis and comparison with the potent cannabinoid metabolites 11-hydroxytetrahydrocannabinols. |
| AID1131787 | Cataleptogenic activity in iv dosed ddN mouse assessed as induction of catalepsy after 30 to 60 mins by bar test | 1978 | Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
| Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol. |
| AID238865 | Inhibition of [3H]CP-55940 binding to cannabinoid receptor 1 of rat brain | 2005 | Journal of medicinal chemistry, Jul-14, Volume: 48, Issue:14
| Adamantyl cannabinoids: a novel class of cannabinergic ligands. |
| AID49003 | The compound was tested in vitro for binding activity against THC cannabinoid receptor site, using 3H-CP-55940 as the radioligand | 1991 | Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
| Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol. |
| AID1131797 | Drug metabolism in mouse liver homogenates assessed as compound hydrolysis at pH 9.6 after 60 mins by spectrophotometric analysis in presence of alkaline phosphatase | 1978 | Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
| Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol. |
| AID416356 | Binding affinity to CB2 receptor | 2009 | Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
| Quantitative structure-activity relationship (QSAR) for a series of novel cannabinoid derivatives using descriptors derived from semi-empirical quantum-chemical calculations. |
| AID1124419 | Induction of overt behavior in dog at 0.20 mg/kg, iv | 1979 | Journal of medicinal chemistry, Jul, Volume: 22, Issue:7
| Some 11-substituted tetrahydrocannabinols. Synthesis and comparison with the potent cannabinoid metabolites 11-hydroxytetrahydrocannabinols. |
| AID1230032 | Neurobehavioral effect on Swiss Webster mouse assessed as locomotor activity measured as total number of interruptions at 5 mg/kg, ip monitored for 30 mins (Rvb = 2091 +/- 209.3 No_unit) by mouse tetrad assay | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID257800 | Displacement of [35S]GTP-gamma-S from rat cerebellar CB1 receptor | 2006 | Journal of medicinal chemistry, Jan-26, Volume: 49, Issue:2
| 3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data. |
| AID223111 | Antinociception measured in terms of the maximum possible effect (MPE)on latency by mouse tail-flick assay | 1992 | Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
| 5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. |
| AID391587 | Displacement of [3H]CP-55940 from CB2 receptor in mouse spleen membrane | 2008 | Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
| Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands. |
| AID1062665 | Displacement of [3H]CP-55,940 from human CB2 receptor expressed in HEK293 cell membranes by scintillation counting analysis | 2013 | Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
| Controlled-deactivation cannabinergic ligands. |
| AID1062667 | Displacement of [3H]CP-55,940 from CB1 receptor in rat brain by scintillation counting analysis | 2013 | Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
| Controlled-deactivation cannabinergic ligands. |
| AID40058 | Psychotropic effects in Baboons at a dose 0.05 mg/kg; + = drowsiness, decreased motor activity, occasional partial ptosis, occasional head drop | 1984 | Journal of medicinal chemistry, Oct, Volume: 27, Issue:10
| Activity of novel aminocannabinoids in baboons. |
| AID414287 | Binding affinity to human CB2 receptor transfected in HEK293 cells | 2009 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
| Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands. |
| AID112374 | The compound was tested in vivo for locomotor activity in mice | 1991 | Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
| Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol. |
| AID1127487 | Selectivity ratio of Ki for rat CB1 receptor to Ki for mouse spleen CB2 receptor | 2013 | Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
| Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. |
| AID1230048 | Neurobehavioral effect on Swiss Webster mouse assessed as decrease in rectal temperature at 5 mg/kg, ip (Rvb = 0.58 +/- 0.26 degC) by mouse tetrad assay | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID221580 | Compound was evaluated by in vivo administration for percent inhibition of locomotion in mice | 1992 | Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
| 5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. |
| AID1230038 | Neurobehavioral effect on Swiss Webster mouse assessed as catalepsy latency time at 20 mg/kg, ip (Rvb = 2.1 +/- 0.60 secs) by mouse tetrad assay | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID406562 | Displacement of [3H]CP-55940 from human CB2 receptor expressed in CHO-K1 cells | 2008 | Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
| Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs. |
| AID1062663 | Half life in mouse plasma at 200 uM by HPLC analysis | 2013 | Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
| Controlled-deactivation cannabinergic ligands. |
| AID1131784 | Acute toxicity in iv dosed ddN mouse assessed as mortality after 24 hrs | 1978 | Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
| Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol. |
| AID1062666 | Displacement of [3H]CP-55,940 from mouse CB2 receptor expressed in HEK293 cell membranes by scintillation counting analysis | 2013 | Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
| Controlled-deactivation cannabinergic ligands. |
| AID1230046 | Neurobehavioral effect on Swiss Webster mouse assessed as hot plate latency time at 20 mg/kg, ip (Rvb = 8.32 +/- 2.20 %) by mouse tetrad assay | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID112376 | The compound was tested in vivo for ring immobility in mice | 1991 | Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
| Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol. |
| AID40184 | Psychotropic effects in baboons at a dose 0.5 mg/kg; +++ = severe stupor and ataxia, full ptosis, immobility, crouched posture lasting for more than 3 h, and absence of reaction to external stimuli | 1984 | Journal of medicinal chemistry, Oct, Volume: 27, Issue:10
| Activity of novel aminocannabinoids in baboons. |
| AID1124418 | Induction of overt behavior in dog at 0.10 mg/kg, iv | 1979 | Journal of medicinal chemistry, Jul, Volume: 22, Issue:7
| Some 11-substituted tetrahydrocannabinols. Synthesis and comparison with the potent cannabinoid metabolites 11-hydroxytetrahydrocannabinols. |
| AID1230050 | Neurobehavioral effect on Swiss Webster mouse assessed as decrease in rectal temperature at 20 mg/kg, ip (Rvb = 0.58 +/- 0.26 degC) by mouse tetrad assay | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID311038 | Binding affinity to CB2 receptor | 2007 | Journal of medicinal chemistry, Jun-14, Volume: 50, Issue:12
| The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2. |
| AID40179 | Psychotropic effects in Baboons at a dose 0.1 mg/kg; ++ = stupor, ataxia, suppression of motor activity, full ptosis, typical crouched posture (thinker position) kept for up to 3 h | 1984 | Journal of medicinal chemistry, Oct, Volume: 27, Issue:10
| Activity of novel aminocannabinoids in baboons. |
| AID1127485 | Binding affinity to rat CB1 receptor | 2013 | Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
| Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. |
| AID1230034 | Neurobehavioral effect on Swiss Webster mouse assessed as locomotor activity measured as total number of interruptions at 20 mg/kg, ip monitored for 30 mins (Rvb = 2091 +/- 209.3 No_unit) by mouse tetrad assay | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6
| Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. |
| AID221057 | Induction of ring immobility (catalepsy), measured by in vivo administration of drug in mouse | 1992 | Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
| 5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. |
| AID1131789 | Potentiation of thiopental-induced sleep in iv dosed ddN mouse assessed as loss of righting reflex after 60 mins administered with 1% Tween-80 | 1978 | Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
| Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol. |
| AID1131790 | Potentiation of thiopental-induced sleep in iv dosed ddN mouse assessed as loss of righting reflex after 30 to 60 mins | 1978 | Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
| Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol. |
| AID223116 | Compound was evaluated by in vivo administration for its ability to produce hypothermia (change in temperature) | 1992 | Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
| 5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. |
| AID40045 | Induction of yawning and scratching was determined in Baboons at a dose 0.5 mg/kg; absent | 1984 | Journal of medicinal chemistry, Oct, Volume: 27, Issue:10
| Activity of novel aminocannabinoids in baboons. |
| AID406561 | Displacement of [3H]CP-55940 from human CB1 receptor expressed in HEK293 cells | 2008 | Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
| Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs. |
| AID1133175 | Molar volume, Vm of the compound at zero temperature | 1978 | Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
| Molar volume relationships and the specific inhibition of a synaptosomal enzyme by psychoactive cannabinoids. |
| AID1131786 | Cataleptogenic activity in iv dosed ddN mouse assessed as induction of catalepsy after 30 mins by bar test | 1978 | Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
| Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol. |
| AID223117 | Compound was evaluated by in vivo administration for its ability to produce sedation | 1992 | Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
| 5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. |
| AID133194 | Psychotropic Effect evaluated by Mouse Ring Test at a dose of 0.1 mg/kg | 1990 | Journal of medicinal chemistry, Mar, Volume: 33, Issue:3
| Cannabimimetic activity of novel enantiomeric, benzofuran cannabinoids. |
| AID1127486 | Binding affinity to mouse spleen CB2 receptor | 2013 | Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
| Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. |
| AID416355 | Binding affinity to CB1 receptor | 2009 | Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
| Quantitative structure-activity relationship (QSAR) for a series of novel cannabinoid derivatives using descriptors derived from semi-empirical quantum-chemical calculations. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |